DE60033381D1 - Verwendung von dreidimensionalem stromalen gewebe zur behandlung von ischemischen gewebe - Google Patents

Verwendung von dreidimensionalem stromalen gewebe zur behandlung von ischemischen gewebe

Info

Publication number
DE60033381D1
DE60033381D1 DE60033381T DE60033381T DE60033381D1 DE 60033381 D1 DE60033381 D1 DE 60033381D1 DE 60033381 T DE60033381 T DE 60033381T DE 60033381 T DE60033381 T DE 60033381T DE 60033381 D1 DE60033381 D1 DE 60033381D1
Authority
DE
Germany
Prior art keywords
tissue
promoting
dimensional stromal
treatment
stromal tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60033381T
Other languages
English (en)
Other versions
DE60033381T2 (de
Inventor
K Naughton
N Mansbridge
E Pinney
Joan Zeltinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Theregen Inc
Original Assignee
Theregen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theregen Inc filed Critical Theregen Inc
Publication of DE60033381D1 publication Critical patent/DE60033381D1/de
Application granted granted Critical
Publication of DE60033381T2 publication Critical patent/DE60033381T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3826—Muscle cells, e.g. smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60033381T 1999-04-12 2000-04-12 Verwendung von dreidimensionalem stromalen gewebe zur behandlung von ischemischen gewebe Expired - Lifetime DE60033381T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12883899P 1999-04-12 1999-04-12
US128838P 1999-04-12
US411585 1999-10-01
US09/411,585 US20030007954A1 (en) 1999-04-12 1999-10-01 Methods for using a three-dimensional stromal tissue to promote angiogenesis
PCT/US2000/009848 WO2000061204A1 (en) 1999-04-12 2000-04-12 Three-dimensional stromal tissue

Publications (2)

Publication Number Publication Date
DE60033381D1 true DE60033381D1 (de) 2007-03-29
DE60033381T2 DE60033381T2 (de) 2007-11-29

Family

ID=26826992

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60033381T Expired - Lifetime DE60033381T2 (de) 1999-04-12 2000-04-12 Verwendung von dreidimensionalem stromalen gewebe zur behandlung von ischemischen gewebe

Country Status (10)

Country Link
US (4) US20030007954A1 (de)
EP (1) EP1169069B1 (de)
JP (1) JP4709393B2 (de)
AT (1) ATE353676T1 (de)
AU (1) AU777853C (de)
CA (1) CA2367507C (de)
DE (1) DE60033381T2 (de)
ES (1) ES2282105T3 (de)
IL (2) IL145892A0 (de)
WO (1) WO2000061204A1 (de)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030007954A1 (en) 1999-04-12 2003-01-09 Gail K. Naughton Methods for using a three-dimensional stromal tissue to promote angiogenesis
US6585716B2 (en) * 2000-04-05 2003-07-01 Biocardia, Inc. Method of treating the heart
DE10191512D2 (de) 2000-04-11 2003-03-13 Univ Heidelberg Umhüllungen und Folien aus Poly-Tri-Fluor-Ethoxypolyphosphazen
US20050095268A1 (en) * 2000-06-12 2005-05-05 Acorn Cardiovascular, Inc. Cardiac wall tension relief with cell loss management
US7326570B2 (en) * 2000-06-16 2008-02-05 The Regents Of The University Of California Induction of tubular morphogenesis using pleiotrophin
US20080152629A1 (en) * 2000-12-06 2008-06-26 James Edinger Placental stem cell populations
DE10100961B4 (de) 2001-01-11 2005-08-04 Polyzenix Gmbh Körperverträglicher Werkstoff und mit diesem Werkstoff beschichtetes Substrat für die Züchtung von Zellen und künstlichen aus Zellen aufgebauten oder gewachsenen organischen Implantaten
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
EP1456358A2 (de) * 2001-09-20 2004-09-15 Centre for Translational Research in Cancer Kultivierte stromazellen und deren verwendung
BR0316695A (pt) * 2002-11-26 2005-10-18 Anthrogenesis Corp Unidade citoterapêutica, kit para tratamento, método de tratamento de uma enfermidade, biblioteca de unidades citoterapêuticas e método de tratamento de um paciente
US8940292B2 (en) * 2003-01-28 2015-01-27 Wake Forest University Health Sciences Enhancement of angiogenesis to grafts using cells engineered to produce growth factors
JP2006517975A (ja) * 2003-02-13 2006-08-03 アンスロジェネシス コーポレーション 疾患、障害または症状を患っている個体を治療するための臍帯血の使用
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US8518390B2 (en) 2003-06-27 2013-08-27 Advanced Technologies And Regenerative Medicine, Llc Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
PL1641916T3 (pl) * 2003-06-27 2016-08-31 Depuy Synthes Products Inc Regeneracja i naprawa tkanki nerwowej z wykorzystaniem komórek poporodowych
US8491883B2 (en) * 2003-06-27 2013-07-23 Advanced Technologies And Regenerative Medicine, Llc Treatment of amyotrophic lateral sclerosis using umbilical derived cells
NZ548049A (en) * 2003-12-02 2009-01-31 Celgene Corp Methods and compositions for the treatment and management of hemoglobinopathy and anemia
US8486438B2 (en) * 2004-01-29 2013-07-16 Brown University Methods for progenitor cell recruitment and isolation
EP1730265B1 (de) * 2004-03-24 2016-02-17 Marisa E. E. Jaconi 3d-gewebetechnologie für die zelltherapie bei herzversagen
US20060154365A1 (en) * 2004-08-30 2006-07-13 Anthony Ratcliffe Cultured three dimensional tissues and uses thereof
US20080226604A9 (en) * 2005-06-17 2008-09-18 Theregen Company Methods for treating ischemic tissue
AU2005279771A1 (en) * 2004-08-30 2006-03-09 Theregen, Inc Cultured three dimensional tissues and uses thereof
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
ATE500855T1 (de) * 2004-11-22 2011-03-15 Theregen Inc Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
US20060153815A1 (en) * 2004-12-21 2006-07-13 Agnieszka Seyda Tissue engineering devices for the repair and regeneration of tissue
US20060171930A1 (en) * 2004-12-21 2006-08-03 Agnieszka Seyda Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
PL1831356T3 (pl) 2004-12-23 2017-07-31 DePuy Synthes Products, Inc. Komórki poporodowe pochodzące z tkanki pępowinowej i sposoby ich wytwarzania i stosowania
WO2006071778A2 (en) 2004-12-23 2006-07-06 Ethicon Incorporated Treatment of parkinson's disease and related disorders using postpartum derived cells
WO2007011644A2 (en) * 2005-07-15 2007-01-25 Cormatrix Cardiovascular, Inc. Compositions for regenerating defective or absent tissue
DE102005045671A1 (de) * 2005-09-15 2007-03-29 Ossacur Ag Verwendung eines Kollagens xenogenen Ursprungs
EP1957633B1 (de) 2005-10-13 2013-12-18 Anthrogenesis Corporation Immunmodulation unter verwendung von plazentastammzellen
WO2007070870A1 (en) * 2005-12-16 2007-06-21 Ethicon, Inc. Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
CN101410511B (zh) * 2005-12-19 2015-02-25 伊西康公司 产后来源的细胞在滚瓶中的体外扩增
PL1979050T3 (pl) * 2005-12-28 2017-09-29 DePuy Synthes Products, Inc. Leczenie chorób naczyń obwodowych z zastosowaniem komórek pochodzenia poporodowego
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
ES2703502T3 (es) 2005-12-29 2019-03-11 Celularity Inc Poblaciones de células madre placentarias
CN101431962A (zh) * 2006-02-07 2009-05-13 器官发生有限公司 生物工程化组织构建物及其心脏用途
ATE537853T1 (de) 2006-10-10 2012-01-15 Celonova Biosciences Inc Bioprothetische herzklappe mit polyphosphazen
US20100129915A1 (en) * 2006-11-09 2010-05-27 Deepak Srivastava Methods for inducing cardiomyogenesis
RS52921B (en) * 2007-02-12 2014-02-28 Anthrogenesis Corporation TREATMENT OF INFLAMMATORY DISEASES USING PLACENTAL CELL CELLS
US20100172830A1 (en) * 2007-03-29 2010-07-08 Cellx Inc. Extraembryonic Tissue cells and method of use thereof
CN101790610A (zh) * 2007-05-04 2010-07-28 魁北克工业研究中心 用于优化木质纤维素颗粒物质磨浆的系统和方法
US20090061473A1 (en) * 2007-08-29 2009-03-05 Rajiv Krishna Saxena Measurement of Carbonaceous Particles in Biological Samples
KR20180107320A (ko) 2007-09-28 2018-10-01 안트로제네시스 코포레이션 인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법
AU2008308531B2 (en) * 2007-10-05 2014-04-24 Ethicon, Incorporated Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells
KR20210056449A (ko) * 2007-11-07 2021-05-18 안트로제네시스 코포레이션 조산 합병증의 치료에 있어서의 제대혈의 용도
US8236538B2 (en) 2007-12-20 2012-08-07 Advanced Technologies And Regenerative Medicine, Llc Methods for sterilizing materials containing biologically active agents
US11051733B2 (en) * 2008-01-18 2021-07-06 Wake Forest University Health Sciences Isolating and purifying cells for therapy
WO2009097559A1 (en) 2008-01-30 2009-08-06 Histogen, Inc. Extracellular matrix compositions
WO2010021715A1 (en) * 2008-08-20 2010-02-25 Anthrogenesis Corporation Treatment of stroke using isolated placental cells
PE20110400A1 (es) * 2008-08-20 2011-06-22 Anthrogenesis Corp Composiciones mejoradas de celulas y metodos para preparar las mismas
JP2012500792A (ja) * 2008-08-22 2012-01-12 アンスロジェネシス コーポレーション 胎盤細胞集団による骨欠損の治療のための方法および組成物
EP2375907B1 (de) * 2008-11-21 2019-02-27 Celularity, Inc. Behandlung von krankheiten, störungen oder leiden der lunge mittels plazentazellen
US10179900B2 (en) * 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
BRPI0923070A2 (pt) * 2008-12-19 2016-06-14 Atrm Llc "usos de composições para regeneração e reparo de tecido neural após lesão, as referidas composições, e kit"
EP2379088B1 (de) 2008-12-19 2018-02-28 DePuy Synthes Products, Inc. Behandlung von lungen und pulmonalen erkrankungen und störungen
CN102481321B (zh) * 2008-12-19 2017-12-19 德普伊新特斯产品公司 用于治疗神经病性疼痛和痉挛状态的脐带组织来源的细胞
EP2411504B1 (de) 2009-03-26 2017-05-10 DePuy Synthes Products, Inc. Humane nabelschnur gewebezellen in der alzheimer therapie
JP2012523238A (ja) 2009-04-09 2012-10-04 ジ・アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ザ・ユニバーシティ・オブ・アリゾナ 三次元繊維芽細胞構築物の細胞播種および共培養
JP2013518108A (ja) * 2010-01-26 2013-05-20 アントフロゲネシス コーポレーション 胎盤幹細胞を用いる骨関連癌の治療
TW201902496A (zh) 2010-04-07 2019-01-16 美商安瑟吉納西斯公司 利用胎盤幹細胞之血管新生
CA2795401A1 (en) 2010-04-08 2011-10-13 Anthrogenesis Corporation Treatment of sarcoidosis using placental stem cells
EP3358007A1 (de) 2010-07-13 2018-08-08 Celularity, Inc. Verfahren zur erzeugung von natürlichen killerzellen
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
WO2012092485A1 (en) 2010-12-31 2012-07-05 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory rna molecules
WO2012166844A2 (en) 2011-06-01 2012-12-06 Anthrogenesis Corporation Treatment of pain using placental stem cells
US9844514B2 (en) * 2011-09-30 2017-12-19 University Of Louisville Research Foundation, Inc. Methods for treating an established myocardial infarction
RU2466688C1 (ru) * 2011-10-12 2012-11-20 Ильгиз Фанусович Хатмуллин Способ лечения послеоперационных анастомозов на органах брюшной полости, осложненных рубцовым стенозированием
RU2636220C2 (ru) 2011-12-23 2017-11-21 Депуи Синтез Продактс, Инк. Обнаружение клеток, полученных из ткани пуповины человека
KR20150059754A (ko) * 2012-09-04 2015-06-02 안트로제네시스 코포레이션 조직 생성 방법
AU2014215458A1 (en) 2013-02-05 2015-08-13 Anthrogenesis Corporation Natural killer cells from placenta
EP3068866B1 (de) 2013-11-16 2018-04-25 Terumo BCT, Inc. Zellenexpansion in einem bioreaktor
EP3613841B1 (de) 2014-03-25 2022-04-20 Terumo BCT, Inc. Passives ersetzen von medien
CN106715676A (zh) 2014-09-26 2017-05-24 泰尔茂比司特公司 按计划供养
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
CN109689853B (zh) 2016-08-27 2022-08-23 三维生物科技有限公司 生物反应器
EP3656841A1 (de) 2017-03-31 2020-05-27 Terumo BCT, Inc. Zellexpansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
SG11201912185XA (en) 2017-06-16 2020-01-30 Avery Therapeutics Inc Three dimensional tissue compositions and methods of use
CN107308504A (zh) * 2017-06-17 2017-11-03 常州帝君金属构件厂 一种心肌仿生支架的制备方法
US11718829B2 (en) 2017-07-28 2023-08-08 Breakthrough Tech Llc Methods and compositions for manufacturing extracellular matrix
JP2021503343A (ja) * 2017-11-17 2021-02-12 アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティー オブ アリゾナ 心臓への適用に最適化された材料特性を有する骨格およびその使用
US12077780B2 (en) 2020-02-14 2024-09-03 Allergan Sales, Llc Conditioned medium from cells cultured under hypoxic conditions and uses thereof
US12043823B2 (en) 2021-03-23 2024-07-23 Terumo Bct, Inc. Cell capture and expansion

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT366916B (de) * 1980-04-02 1982-05-25 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes auf basis von menschlichen oder tierischenproteinen
US4627879A (en) * 1984-09-07 1986-12-09 The Trustees Of Columbia University In The City Of New York Fibrin adhesive prepared as a concentrate from single donor fresh frozen plasma
US4721096A (en) * 1986-04-18 1988-01-26 Marrow-Tech Incorporated Process for replicating bone marrow in vitro and using the same
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US4963489A (en) * 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5902741A (en) * 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5032508A (en) * 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5290552A (en) * 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
US4874368A (en) * 1988-07-25 1989-10-17 Micromedics, Inc. Fibrin glue delivery system
JPH0762078B2 (ja) 1989-03-03 1995-07-05 松下電器産業株式会社 有機薄膜の形成方法
JP2678945B2 (ja) * 1989-04-17 1997-11-19 有限会社ナイセム 人工血管とその製造方法及び人工血管用基質
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
US5368563A (en) * 1991-12-18 1994-11-29 Micromedics, Inc. Sprayer assembly for physiologic glue
US5478739A (en) * 1992-10-23 1995-12-26 Advanced Tissue Sciences, Inc. Three-dimensional stromal cell and tissue culture system
GB9306449D0 (en) * 1993-03-29 1993-05-19 Nat Heart Research Fund Tissue equivalents
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
AU2195095A (en) * 1994-03-24 1995-10-09 University Of Washington Devices and methods for implanting transduced cells
EP0781116A4 (de) * 1994-09-12 1999-08-25 Advanced Tissue Sciences Inc Dreidimensionale kulturen von menschlichen zellen auf herzklappengerüst und ihreverwendung
US5605541A (en) * 1994-12-07 1997-02-25 E. R. Squibb And Sons, Inc. Fibrin sealant applicatoor
US5643192A (en) * 1995-04-06 1997-07-01 Hamilton Civic Hospitals Research Development, Inc. Autologous fibrin glue and methods for its preparation and use
US6284284B1 (en) * 1995-06-06 2001-09-04 Advanced Tissue Sciences, Inc. Compositions and methods for production and use of an injectable naturally secreted extracellular matrix
US5830708A (en) * 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
US5843766A (en) * 1995-06-07 1998-12-01 Advanced Tissue Sciences, Inc. Apparatus for the growth and packaging of three dimensional tissue cultures
US5763267A (en) * 1996-04-16 1998-06-09 Advanced Tissue Sciences Apparatus for the large scale growth and packaging of cell suspensions and three-dimensional tissue cultures
US5759171A (en) * 1996-09-27 1998-06-02 Thermogenesis Corp. Sprayer for fibrin glue
US6099832A (en) * 1997-05-28 2000-08-08 Genzyme Corporation Transplants for myocardial scars
DE59803925D1 (de) * 1997-06-27 2002-05-29 Augustinus Bader Bioartifizielles transplantat und verfahren zu seiner herstellung
US6886568B2 (en) * 1998-04-08 2005-05-03 The Johns Hopkins University Method for fabricating cell-containing implants
US6303136B1 (en) 1998-04-13 2001-10-16 Neurotech S.A. Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
AU2171900A (en) * 1998-12-11 2000-06-26 Advance Tissue Sciences, Inc. Application of shear flow stress to smooth muscle cells for the production of implantable structures
US6662805B2 (en) * 1999-03-24 2003-12-16 The Johns Hopkins University Method for composite cell-based implants
US20030007954A1 (en) 1999-04-12 2003-01-09 Gail K. Naughton Methods for using a three-dimensional stromal tissue to promote angiogenesis
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
US6730016B1 (en) * 2000-06-12 2004-05-04 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US6719970B1 (en) * 2000-07-10 2004-04-13 Alkermes Controlled Therapeutics, Inc. Method of generating cartilage
US20030211088A1 (en) * 2001-03-12 2003-11-13 Field Loren J. Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same
US20040203146A1 (en) * 2001-04-30 2004-10-14 Dan Gazit Composite scaffolds and methods using same for generating complex tissue grafts
US20030003089A1 (en) * 2001-05-11 2003-01-02 Akins Robert E. Tissue engineered cardiac constructs
EP1367119B1 (de) 2002-05-28 2008-09-17 Toyo Boseki Kabushiki Kaisha Verfahren zur Kultur, zum Speichern und zur Induzierung von Differenzierung von Zellen und Gerät zur Verwendung in diesem Verfahren, und dazugehöriges Gebrauchsverfahren.
KR100483863B1 (ko) 2002-12-27 2005-04-15 메디칸(주) 고체분말을 이용한 3차원 세포 배양방법
WO2004074457A2 (en) 2003-02-20 2004-09-02 Macropore Biosurgery, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US20080226604A9 (en) * 2005-06-17 2008-09-18 Theregen Company Methods for treating ischemic tissue
US20060154365A1 (en) * 2004-08-30 2006-07-13 Anthony Ratcliffe Cultured three dimensional tissues and uses thereof
ATE500855T1 (de) * 2004-11-22 2011-03-15 Theregen Inc Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen

Also Published As

Publication number Publication date
CA2367507A1 (en) 2000-10-19
EP1169069A1 (de) 2002-01-09
ES2282105T3 (es) 2007-10-16
IL145892A (en) 2009-06-15
AU777853B2 (en) 2004-11-04
JP2002541221A (ja) 2002-12-03
WO2000061204A1 (en) 2000-10-19
AU777853C (en) 2005-08-11
US20030007954A1 (en) 2003-01-09
AU4456400A (en) 2000-11-14
JP4709393B2 (ja) 2011-06-22
IL145892A0 (en) 2002-07-25
EP1169069B1 (de) 2007-02-14
US20110213470A1 (en) 2011-09-01
US20040219134A1 (en) 2004-11-04
CA2367507C (en) 2009-12-29
DE60033381T2 (de) 2007-11-29
US8128924B2 (en) 2012-03-06
ATE353676T1 (de) 2007-03-15
US20090269316A1 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
DE60033381D1 (de) Verwendung von dreidimensionalem stromalen gewebe zur behandlung von ischemischen gewebe
McKee Microvascular bone transplantation
US4516276A (en) Bone substitute and a method of production thereof
Hartman et al. Donor-site complications in vascularized bone flap surgery
Yim et al. Fibula osteoseptocutaneous free flap in maxillary reconstruction
DE69813908D1 (de) Verwendung von kreatinsubstanzen zur behandlung von knochen- und knorpelzellen und geweben
CN113164645A (zh) 获得脱细胞的细胞外基质的方法，脱细胞的细胞外基质，其用途和试剂盒
Osterman et al. Free vascularized bone grafting for large-gap nonunion of long bones
WO2003061455A3 (en) An apical patch and method of use
ATE371418T1 (de) Versteifungswand zur behandlung von geschädigtem gewebe der bauchwand
Kildal et al. Free vascularized bone grafts for reconstruction of traumatic bony defects of mandible and maxilla
Dingman et al. The surgical repair of traumatic defects of the scalp
RU2523353C1 (ru) Способ костной пластики нижней челюсти
CN110430903A (zh) 组织基质材料和酶粘合剂
RU194186U1 (ru) Многозвеньевая реконструктивная пластина нижней челюсти
RU2295924C1 (ru) Способ пластики кожных покровов после ранней некрэктомии
EP1782849A3 (de) Dreidimensionales Bindegewebe
EP0968729A3 (de) Knochenregenerierungsmaterial
RU2003112493A (ru) Способ лечения раны после удаления зуба или имплантата
RU2369348C1 (ru) Способ лечения остеомиелита длинных трубчатых костей с дефектом покровных тканей
SU1537234A1 (ru) Способ костной пластики проксимального отдела бедренной кости
RU2295305C1 (ru) Способ замещения послеоперационных субтотальных дефектов дна полости рта и языка
RU2141792C1 (ru) Способ нейрососудистой пластики
RU2176482C2 (ru) Способ пластики дефекта нервного ствола
RU2610534C1 (ru) Способ лечения дефектов четвертой пястной кости

Legal Events

Date Code Title Description
8364 No opposition during term of opposition